中文产业新闻评分58Chinese source
艾力斯伏美替尼FURVENT三期试验未达主要终点
III期临床失利！年销售超50亿创新药遇阻
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
III期临床失利！年销售超50亿创新药遇阻
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.